Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Convertible Preferred Stock
Common Stock
Common Stock
Class A and Class B Common Stock
Additional Paid-in Amount
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2021   120,903 95,456 0   14,131    
Beginning balance at Jan. 31, 2021 $ 193,853 $ 424,992 $ 4 $ 0 $ 122,061 $ (23,831) $ 787 $ (330,160)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation - equity classified awards 8,657       8,657      
Exercise of stock options (in shares)     5,692          
Exercise of stock options 8,006       8,006      
Other comprehensive income (loss) (400)           (400)  
Net loss (14,493)             (14,493)
Ending balance (in shares) at Apr. 30, 2021   120,903 101,148 0   14,131    
Ending balance at Apr. 30, 2021 195,623 $ 424,992 $ 4 $ 0 138,724 $ (23,831) 387 (344,653)
Beginning balance (in shares) at Jan. 31, 2022   0 0 256,481   14,131    
Beginning balance at Jan. 31, 2022 515,849 $ 0 $ 0 $ 8 982,122 $ (23,831) (820) (441,630)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation - equity classified awards 12,462       12,462      
Exercise of stock options and release of vested restricted stock units (in shares)       1,464        
Exercise of stock options and release of vested restricted stock units $ 6,518       6,518      
Exercise of stock options (in shares) 1,404              
Other comprehensive income (loss) $ (3,183)           (3,183)  
Net loss (25,288)             (25,288)
Ending balance (in shares) at Apr. 30, 2022   0 0 257,945   14,131    
Ending balance at Apr. 30, 2022 $ 506,358 $ 0 $ 0 $ 8 $ 1,001,102 $ (23,831) $ (4,003) $ (466,918)